|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/7068 | |||
| A61P 9/10 |
| (11) | Patento numeris | 3046627 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14845184.2 |
| Europos patento paraiškos padavimo data | 2014-09-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/055680 |
| Data | 2014-09-15 |
| (87) | Numeris | WO 2015/041987 |
| Data | 2015-03-26 |
| (30) | Numeris | Data | Šalis |
| 201361879562 P | 2013-09-18 | US |
| (72) |
LEEPER, Nicholas J., US
WEISSMAN, Irving L., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE |
| MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE |